- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 235/32 - Benzimidazole-2-carbamic acids, unsubstituted or substitutedEsters thereofThio-analogues thereof
Patent holdings for IPC class C07D 235/32
Total number of patents in this class: 51
10-year publication summary
|
4
|
2
|
6
|
4
|
3
|
2
|
5
|
3
|
3
|
4
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Korea University Research and Business Foundation | 3202 |
5 |
| Beth Israel Deaconess Medical Center, Inc. | 862 |
4 |
| Children's Medical Center Corporation | 1941 |
4 |
| The Johns Hopkins University | 5844 |
3 |
| Intervet International B.V. | 1342 |
2 |
| Korea Research Institute of Chemical Technology | 1458 |
2 |
| University of Washington through its Center for Commercialization | 504 |
2 |
| Institute of Organic Chemistry and Biochemistry AS CR V.v.i. | 32 |
2 |
| Boehringer Ingelheim International GmbH | 4494 |
1 |
| Merck Patent GmbH | 5669 |
1 |
| Bayer Intellectual Property GmbH | 2395 |
1 |
| Amgen Inc. | 4383 |
1 |
| Board of Regents of the University of Nebraska | 793 |
1 |
| Board of Supervisors of Louisiana State University and Agricultural and Mechanical College | 824 |
1 |
| Carna Biosciences, Inc. | 66 |
1 |
| Gilead Sciences, Inc. | 2207 |
1 |
| Intervet Inc. | 918 |
1 |
| Istituto Superiore di Sanita | 74 |
1 |
| Kyoto University | 2898 |
1 |
| MediciNova, Inc. | 91 |
1 |
| Other owners | 15 |